Home › Sjögren's Disease › Missouri › Kansas City
Sjögren's Disease clinical trials in Kansas City, MO
3 studies for Sjögren's Disease are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Kansas City Physician Partners, Kansas City
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- Kansas City Physician Partners-8350 N Saint Clair Ave, Kansas City
About Sjögren's Disease
Sjögren's disease is an autoimmune disease that causes dryness of the mouth, eyes, and other parts of the body. Learn how to relieve the symptoms.
More about Sjögren's Disease on MedlinePlus
Sjögren's Disease trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Tampa, FL4 studies
- Clearwater, FL4 studies
- Cicero, IL4 studies
- Arlington, TX4 studies
- Charlotte, NC4 studies
- Oklahoma City, OK3 studies
- Memphis, TN3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer29 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer18 studies
- Colorectal Cancer16 studies
- Prostate Cancer16 studies
- Metastatic Cancer14 studies
- Acute Myeloid Leukemia14 studies
- Ovarian Cancer12 studies
- Type 2 Diabetes11 studies
- Cardiovascular Disease11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.